Skip to content

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research

Unveiling Follicular Lymphoma Clinical Trials: Analyzing Patient Engagement Patterns and Participation Trends

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06049485
Enrollment
500
Registered
2023-09-22
Start date
2024-10-31
Completion date
2026-10-31
Last updated
2023-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Follicular Lymphoma

Keywords

follicular lymphoma

Brief summary

Historically, participation in medical studies is highly skewed towards particular demographic groups of people. This research will invite several participants to gather a wide range of information on clinical trial experiences for follicular lymphoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of follicular lymphoma. The data collected from this study will help improve future outcomes for all follicular lymphoma patients as well as those in under-represented demographic groups.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant must be 18 years of age or older * Patient has been diagnosed with follicular lymphoma * Patient has access to a home internet connection in order to provide regular updates through the course of the study

Exclusion criteria

* Women of childbearing potential without a negative pregnancy test; or women who are lactating. * Inability to provide written informed consent * Patients receiving any other investigational agents

Design outcomes

Primary

MeasureTime frame
Number of patients who decide to enroll in a follicular lymphoma clinical research3 months
Rate of patients who remain in a follicular lymphoma medical study to trial completion12 months

Countries

United States

Contacts

Primary ContactMichael B Gill
bask@withpower.com(415) 900-4227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026